NASDAQ · Biotechnology
ATAI Life Sciences BV (ATAI)
$7.35
0.00%
62
In band
Moving averages
SMA 200$4.74+55.06%
Company profile
ATAI Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018 and is headquartered in Berlin, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$2.73B
P/E ratioNone
EPS$-2.79
Beta1.552
52-week high$7.45
52-week low$3.27
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
VKTX
Viking Therapeutics Inc
RSI 44
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
TARS
Tarsus Pharmaceuticals Inc
RSI 54
SRPT
Sarepta Therapeutics Inc
RSI 29
RSI alerts for ATAI
An email when ATAI closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:52 AM EST